跳至主要内容
临床试验/NCT01677169
NCT01677169已完成2 期

Double Blind, Randomized, Placebo-controlled Clinical Trial of the Effect of Noni Juice on Lipid Peroxidation-derived DNA Adducts in Current Heavy Smokers

Tahitian Noni International, Inc.2 个研究点 分布在 1 个国家目标入组 317 人开始时间: 2000年9月最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
已完成
入组人数
317
试验地点
2
主要终点
LOOH and MDA-DNA adducts

研究概览

简要总结

The purpose of this study was to determine if noni juice reduces lipid hydroperoxide (LOOH) and malondialdehyde (MDA) derived-DNA adducts, markers of oxidative DNA damage, in peripheral blood lymphocytes of cigarette smokers.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 to 65 years in age, smoker of more than 20 cigarettes per day, a smoking history exceeding one year, and willing to complete a one month trial.

排除标准

  • concurrent use, or use in the previous three months, of prescription medication or antioxidant vitamins

研究组 & 干预措施

29.5 mL noni dose

Experimental

Ingestion of 29.5 mL of Tahitian Noni® juice (mixture of noni juice and grape and blueberry juices) daily for 30 days.

干预措施: Noni juice (Dietary Supplement)

59 mL noni juice

Experimental

Ingestion of 59 mL of Tahitian Noni® juice (mixture of noni juice and grape and blueberry juices) twice daily (118 mL daily total) for 30 days.

干预措施: Noni juice (Dietary Supplement)

Placebo

Placebo Comparator

Ingestion of 59 mL of placebo (mixture of grape and blueberry juices and natural cheese flavor) twice daily (118 mL daily total) for 30 days.

干预措施: Placebo (Dietary Supplement)

结局指标

主要结局

LOOH and MDA-DNA adducts

时间窗: 1 month

LOOH and MDA-DNA adducts in lymphocytes immediately prior to intervention and at completion of intervention.

次要结局

  • adverse events(1 month)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验